Cellworks Research India Private Limited

Cellworks’ mission is to serve patients through advances in personalized medicine that significantly improve treatment success. We achieve better outcomes by predicting a successful match between patients and drug therapies – their Therapy Response Index (TRI). Our technology goes beyond the “one mutation, one drug” NGS paradigm, to consider multiple aberrations and to evaluate alternative therapy options, which provides actionable information and analysis. In the clinical setting, our products provide physicians with a TRI report that informs therapy choices. We change the economics of drug development and targeting by assisting BioPharma in accomplishing higher clinical trial success rates and resurrecting failed drugs. We drive down costs across the healthcare system by cutting out the trial and error of therapy selection, and provide payors with transparency into the causative rationale of therapeutic recommendations.